Gregory K Albaugh, DO
Vascular Surgery · Oxnard
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 32 years
- College of Osteo Med of the Pacific at Pomona, 1994
Offices
1 location · Coastal Vascular Center PC · 4 clinicians in this group
Hospitals listed: Community Memorial Hospital - Ventura · St Johns Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Albaugh’s office at (805) 983-6233 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Memorial Hospital - VenturaVentura, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Memorial Health System, which runs 2 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.478, Oct 2024 – Sep 2025
- St Johns Regional Medical CenterOxnard, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.06 (90.32 to 169.81) · 120 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.404, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Memorial Hospital - Ventura
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.478 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.95) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.49 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.27 (93.9 to 200.65) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 86 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 120 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 363 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,592 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,727 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 5,976 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.57 to 5.64) · 1,733 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 688 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.97 (1.53 to 4.4) · 1,669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.87 (1.2 to 14.54) · 661 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.35 to 8.61) · 686 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 327 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.93) · 3,678 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 218 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.548 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.157 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.228 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 249 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 649 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.8 · 157 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -40.6 · 357 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 619 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 8) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.1 to 13) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 164 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.7 to 14.7) · 1,178 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 986 cases | No different | Jan 2024 – Dec 2024 |
What patients said (949 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for St Johns Regional Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.06 (90.32 to 169.81) · 120 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.404 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 1,494 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.56 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.7 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 580 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 654 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,404 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 8,124 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.39) · 8,331 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.92 (1.89 to 5.95) · 1,414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.17 (0.6 to 3.75) · 412 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.94 (0.46 to 3.43) · 1,361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.75 (0.73 to 12.78) · 439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.94 (3.39 to 10.49) · 383 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.11 (0 to 0.67) · 7,172 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 88 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.236 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.331 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.571 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.737 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 336 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 715 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -8.1 · 284 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.1 · 674 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 670 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (5.2 to 8.9) · 428 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (8.6 to 13.5) · 428 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.5 to 18.8) · 247 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 486 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,151 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$255,507
Medicare paid this office $255,507 for 248 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 31 | $53,609 | $1,011 |
| Injection of chemical agent into multiple incompetent veins of leg | 59 | $49,879 | $233 |
| Short return visit (20+ min) | 184 | $34,506 | $76 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 11 | $15,908 | $1,136 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 64 | $12,077 | $163 |
See all 12 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 31 | $53,609 | $1,011 |
| Injection of chemical agent into multiple incompetent veins of leg | 59 | $49,879 | $233 |
| Short return visit (20+ min) | 184 | $34,506 | $76 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 11 | $15,908 | $1,136 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 64 | $12,077 | $163 |
| Ultrasound of leg arteries or artery grafts | 28 | $9,147 | $223 |
| Strapping, unna boot | 19 | $8,548 | $66 |
| Ultrasonic guidance for blood vessel access | 62 | $7,893 | $36 |
| New patient visit (30+ min) | 55 | $4,707 | $86 |
| Ultrasound of both sides of head and neck blood flow | 15 | $2,426 | $162 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $1,690 | $106 |
| Ultrasonic guidance for blood vessel access | 13 | $210 | $12 |
Procedures Medicare counted
| Leg revascularization (restoring blood flow) | 22 | More than 76% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Varicose vein removal | 355 | More than 95% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of chemical agent into multiple incompetent veins of leg | 116 | 148 | 153 | 176 | 238 | 214 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 36 | 57 | 64 | 78 | 55 | 53 |
| Strapping, unna boot | – | – | 102 | 107 | – | 130 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 17 | 24 | 20 | 14 | – | 14 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | – | 14 | 11 | 26 | 19 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
248 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 21% · Women 56% · Also on Medicaid 34% · Health risk score 2.46. Above the middle of the specialty; the typical vascular surgery clinician is at 2.33.
Conditions among them: High blood pressure 75% · Diabetes 42% · Chronic kidney disease 38% · Coronary heart disease 34% · Heart failure 31% · Atrial fibrillation 27% · COPD 20% · Depression 20% · Cancer 18% · Stroke 11% · Dementia 7%.
The office billed $942,332, Medicare allowed $328,935 and paid $255,507; for 1,476 services of 73 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 248 | 1,476 | 75 | 2.46 | $942,332 | $255,507 |
| 2023 | 272 | 1,615 | 75 | 2.73 | $1,037,061 | $265,300 |
| 2022 | 241 | 1,587 | 73 | 3.01 | $1,306,627 | $336,519 |
| 2021 | 245 | 1,433 | 74 | 2.89 | $911,337 | $294,067 |
| 2020 | 265 | 1,417 | 74 | 3.41 | $919,044 | $316,403 |
| 2019 | 302 | 1,310 | 74 | 3.55 | $857,383 | $267,571 |
| 2018 | 292 | 1,440 | 73 | 3.18 | $1,167,359 | $361,005 |
| 2017 | 271 | 1,216 | 73 | 3.44 | $1,202,120 | $372,381 |
| 2016 | 138 | 378 | 72 | 3.53 | $400,797 | $121,613 |
| 2015 | 544 | 2,093 | 74 | 3.07 | $1,686,953 | $519,614 |
| 2014 | 763 | 3,160 | 74 | 2.67 | $2,182,025 | $669,425 |
| 2013 | 1,154 | 3,686 | 75 | 2.92 | $2,579,871 | $756,473 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Injection of chemical agent into multiple incompetent veins of leg | 61 | $57,458 | $241 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 29 | $56,511 | $1,027 |
| Short return visit (20+ min) | 193 | $37,161 | $73 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 70 | $13,623 | $158 |
| Ultrasound of leg arteries or artery grafts | 33 | $9,630 | $214 |
| Ultrasonic guidance for blood vessel access | 67 | $8,558 | $35 |
| New patient visit (30+ min) | 70 | $6,153 | $88 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 15 | $4,774 | $251 |
| Ultrasound of both sides of head and neck blood flow | 14 | $2,257 | $150 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 17 | $2,059 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,513 | $101 |
| Review by radiologist of abdominal aorta image | 11 | $578 | $53 |
| Ultrasonic guidance for blood vessel access | 16 | $203 | $11 |
2022: 13 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 41 | $82,039 | $1,052 |
| Short return visit (20+ min) | 182 | $43,307 | $73 |
| Injection of chemical agent into multiple incompetent veins of leg | 52 | $42,956 | $244 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 13 | $16,154 | $1,154 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 62 | $13,465 | $162 |
| Ultrasound of leg arteries or artery grafts | 30 | $7,895 | $202 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 19 | $6,693 | $257 |
| Strapping, unna boot | 16 | $6,341 | $59 |
| Ultrasonic guidance for blood vessel access | 56 | $6,211 | $35 |
| New patient visit (30+ min) | 72 | $5,685 | $79 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $2,728 | $101 |
| Ultrasound of both sides of head and neck blood flow | 16 | $2,673 | $167 |
| Review by radiologist of abdominal aorta image | 13 | $739 | $49 |
2021: 13 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 37 | $79,670 | $1,245 |
| Short return visit (20+ min) | 183 | $41,309 | $75 |
| Injection of chemical agent into multiple incompetent veins of leg | 41 | $38,734 | $253 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 16 | $24,823 | $1,241 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 62 | $13,938 | $170 |
| Ultrasound of leg arteries or artery grafts | 37 | $12,117 | $229 |
| Strapping, unna boot | 12 | $6,573 | $64 |
| New patient visit (30+ min) | 60 | $5,424 | $90 |
| Ultrasonic guidance for blood vessel access | 43 | $5,089 | $34 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 11 | $3,045 | $277 |
| Ultrasound of both sides of head and neck blood flow | 12 | $2,154 | $154 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 15 | $1,860 | $103 |
| Ultrasonic guidance for blood vessel access | 12 | $128 | $11 |
2020: 14 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 32 | $74,330 | $1,304 |
| Injection of chemical agent into multiple incompetent veins of leg | 42 | $36,224 | $245 |
| Short return visit (20+ min) | 186 | $29,818 | $61 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 21 | $29,194 | $1,216 |
| Ultrasound of leg arteries or artery grafts | 39 | $12,879 | $226 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 56 | $11,715 | $167 |
| New patient visit (30+ min) | 67 | $5,638 | $84 |
| Ultrasonic guidance for blood vessel access | 49 | $4,862 | $33 |
| Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | 12 | $3,905 | $279 |
| Ultrasound of both sides of head and neck blood flow | 17 | $3,304 | $174 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $2,791 | $112 |
| Review by radiologist of abdominal aorta image | 18 | $1,112 | $59 |
| Ultrasound of both sides of head and neck blood flow | 11 | $372 | $34 |
| Ultrasonic guidance for blood vessel access | 11 | $146 | $12 |
2019: 15 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 20 | $49,715 | $1,381 |
| Short return visit (20+ min) | 198 | $26,816 | $59 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 15 | $19,871 | $1,169 |
| Injection of chemical agent into multiple incompetent veins of leg | 37 | $19,562 | $169 |
| Ultrasound of leg arteries or artery grafts | 48 | $13,722 | $218 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 61 | $10,709 | $162 |
| New patient visit (30+ min) | 67 | $5,637 | $84 |
| Ultrasound of both sides of head and neck blood flow | 19 | $3,623 | $173 |
| Ultrasonic guidance for blood vessel access | 42 | $2,925 | $28 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 18 | $2,382 | $104 |
| Ultrasound of one leg arteries or artery grafts | 11 | $1,400 | $108 |
| Review by radiologist of abdominal aorta image | 15 | $730 | $46 |
| Ultrasound of leg arteries or artery grafts | 18 | $591 | $33 |
| Ultrasound of both sides of head and neck blood flow | 14 | $469 | $33 |
| Ultrasonic guidance for blood vessel access | 18 | $205 | $11 |
2018: 14 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 35 | $90,543 | $1,293 |
| Short return visit (20+ min) | 210 | $31,655 | $59 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 22 | $27,863 | $1,072 |
| Injection of chemical agent into multiple incompetent veins of leg | 35 | $19,756 | $158 |
| Ultrasound of leg arteries or artery grafts | 45 | $16,411 | $234 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 78 | $15,481 | $161 |
| New patient visit (30+ min) | 76 | $6,026 | $79 |
| Ultrasound of both sides of head and neck blood flow | 23 | $4,263 | $164 |
| Strapping, unna boot | 15 | $2,716 | $57 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 11 | $2,541 | $195 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 17 | $2,011 | $106 |
| Ultrasonic guidance for blood vessel access | 32 | $1,881 | $24 |
| Review by radiologist of abdominal aorta image | 12 | $533 | $44 |
| Ultrasonic guidance for blood vessel access | 12 | $140 | $12 |
2017: 15 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 33 | $90,900 | $1,398 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 25 | $37,451 | $1,070 |
| Short return visit (20+ min) | 155 | $22,364 | $59 |
| Ultrasound of leg arteries or artery grafts | 33 | $11,736 | $235 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 47 | $10,574 | $168 |
| Injection of chemical agent into multiple incompetent veins of leg | 17 | $9,399 | $192 |
| Return visit (30+ min) | 76 | $7,917 | $84 |
| New patient visit (45+ min) | 47 | $6,123 | $130 |
| Ultrasound of both sides of head and neck blood flow | 18 | $3,662 | $174 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 23 | $2,969 | $106 |
| Strapping, unna boot | 18 | $2,658 | $48 |
| New patient visit (30+ min) | 27 | $2,301 | $85 |
| Ultrasound of both sides of head and neck blood flow | 29 | $973 | $34 |
| Review by radiologist of abdominal aorta image | 12 | $556 | $46 |
| Ultrasonic guidance for blood vessel access | 13 | $169 | $12 |
2016: 8 services
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 15 | $18,768 | $1,173 |
| Insertion of needle and/or catheter for dialysis | 23 | $9,822 | $393 |
| Short return visit (20+ min) | 74 | $6,408 | $56 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $2,680 | $167 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 15 | $1,988 | $124 |
| Ultrasound of both sides of head and neck blood flow | 11 | $1,835 | $167 |
| New patient visit (30+ min) | 20 | $1,772 | $89 |
| Ultrasound of both sides of head and neck blood flow | 15 | $506 | $34 |
2015: 25 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 49 | $128,281 | $1,410 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 20 | $34,969 | $1,093 |
| Short return visit (20+ min) | 276 | $33,534 | $58 |
| Injection of chemical agent into multiple incompetent veins of leg | 48 | $27,887 | $215 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 88 | $18,488 | $174 |
| Ultrasound of leg arteries or artery grafts | 55 | $18,204 | $202 |
| Insertion of needle and/or catheter for dialysis | 27 | $13,233 | $401 |
| Removal of plaque and insertion of stents in arteries of leg | 13 | $8,581 | $613 |
| Ultrasound of both sides of head and neck blood flow | 25 | $5,543 | $179 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 38 | $5,526 | $108 |
| New patient visit (30+ min) | 63 | $5,319 | $84 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 21 | $4,308 | $123 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 11 | $3,107 | $194 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 96 | $3,071 | $29 |
| Return visit (30+ min) | 21 | $2,091 | $84 |
| Ultrasound of both sides of head and neck blood flow | 59 | $1,928 | $33 |
| Insertion of needle and/or catheter for dialysis | 16 | $1,753 | $80 |
| New patient visit (45+ min) | 12 | $1,694 | $141 |
| Review by radiologist of abdominal aorta image | 29 | $1,515 | $47 |
| Strapping, unna boot | 14 | $1,453 | $42 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 45 | $876 | $18 |
| Ultrasonic guidance for blood vessel access | 22 | $854 | $28 |
| Ultrasound of leg arteries or artery grafts | 15 | $596 | $33 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 12 | $591 | $42 |
| Ultrasonic guidance for blood vessel access | 41 | $569 | $12 |
2014: 32 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 66 | $141,128 | $1,486 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 29 | $61,295 | $1,157 |
| Short return visit (20+ min) | 303 | $49,996 | $58 |
| Injection of chemical agent into multiple incompetent veins of leg | 37 | $26,125 | $199 |
| Ultrasound of leg arteries or artery grafts | 73 | $21,006 | $204 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 122 | $20,629 | $159 |
| Insertion of needle and/or catheter for dialysis | 32 | $18,125 | $386 |
| Return visit (30+ min) | 127 | $13,060 | $85 |
| New patient visit (45+ min) | 93 | $11,584 | $125 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 74 | $10,761 | $101 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 30 | $7,308 | $131 |
| Ultrasound of both sides of head and neck blood flow | 34 | $6,938 | $169 |
| Removal of plaque in arteries of leg | 13 | $6,887 | $492 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 11 | $6,308 | $573 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 179 | $6,044 | $29 |
| New patient visit (30+ min) | 54 | $4,456 | $83 |
| Insertion of stent in arteries of leg | 11 | $4,256 | $387 |
| Strapping, unna boot | 15 | $3,535 | $45 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 13 | $3,048 | $218 |
| Ultrasound of one leg arteries or artery grafts | 19 | $2,913 | $127 |
| Ultrasound of both sides of head and neck blood flow | 113 | $2,841 | $25 |
| Ultrasound of hemodialysis access | 14 | $2,168 | $128 |
| Review by radiologist of abdominal aorta image | 41 | $2,001 | $45 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 90 | $1,866 | $18 |
| Removal of tunneled central venous tube | 13 | $1,709 | $131 |
| Insertion of needle and/or catheter for dialysis | 17 | $1,580 | $83 |
| Ultrasound of leg arteries or artery grafts | 31 | $1,047 | $33 |
| Review by radiologist of arm or leg artery image | 15 | $672 | $45 |
| Ultrasonic guidance for blood vessel access | 31 | $396 | $12 |
| Ultrasound of one leg arteries or artery grafts | 15 | $345 | $20 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 15 | $234 | $16 |
| Complete ultrasound study of arm and leg arteries | 11 | $200 | $18 |
2013: 40 services
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 50 | $126,818 | $1,691 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 53 | $114,150 | $1,153 |
| Short return visit (20+ min) | 320 | $41,224 | $59 |
| Insertion of needle and/or catheter for dialysis | 58 | $36,370 | $413 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 122 | $22,204 | $163 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 12 | $21,692 | $1,808 |
| Ultrasound of leg arteries or artery grafts | 89 | $20,523 | $172 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 438 | $13,473 | $28 |
| Removal of plaque in artery of leg, initial vessel | 17 | $13,339 | $580 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 53 | $12,341 | $129 |
| Removal of plaque in arteries of leg | 24 | $9,693 | $373 |
| New patient visit (30+ min) | 114 | $9,623 | $84 |
| Return visit (30+ min) | 84 | $9,354 | $88 |
| Injection of chemical agent into multiple incompetent veins of leg | 17 | $9,295 | $198 |
| Ultrasound of both sides of head and neck blood flow | 51 | $9,257 | $165 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 53 | $7,754 | $105 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 23 | $6,871 | $254 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 11 | $6,371 | $579 |
| New patient visit (45+ min) | 46 | $6,307 | $137 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 25 | $4,724 | $143 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 18 | $4,096 | $228 |
| Ultrasound of both sides of head and neck blood flow | 157 | $3,792 | $24 |
| Ultrasound of hemodialysis access | 29 | $3,695 | $103 |
| Strapping, unna boot | 21 | $3,673 | $50 |
| Insertion of needle and/or catheter for dialysis | 35 | $3,300 | $85 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 13 | $3,192 | $228 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 137 | $2,640 | $17 |
| Ultrasound of one leg arteries or artery grafts | 15 | $2,248 | $112 |
| Review by radiologist of arm or leg artery image | 41 | $2,099 | $45 |
| Short return visit | 38 | $1,970 | $38 |
| Review by radiologist of abdominal aorta image | 36 | $1,828 | $45 |
| Ultrasound of leg arteries or artery grafts | 49 | $1,738 | $32 |
| Short return visit (20+ min) | 19 | $1,046 | $42 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 25 | $678 | $21 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $622 | $48 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 15 | $608 | $41 |
| Short return visit | 14 | $388 | $20 |
| Ultrasonic guidance for blood vessel access | 26 | $311 | $12 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 18 | $273 | $15 |
| Complete ultrasound study of arm and leg arteries | 12 | $204 | $17 |
Medicaid work
$18,607 in 2024
Medicaid paid $18,607 for 389 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 99 | $9,605 |
| Short return visit (20+ min) | 168 | $4,818 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 108 | $3,223 |
| New patient visit (30+ min) | 14 | $961 |
| 2024 | 389 | 4 | 23 | $18,607 |
| 2023 | 562 | 3 | 28 | $26,935 |
| 2022 | 669 | 3 | 30 | $31,900 |
| 2021 | 739 | 3 | 36 | $39,983 |
| 2020 | 973 | 4 | 38 | $66,138 |
| 2019 | 587 | 3 | 36 | $28,129 |
| 2018 | 305 | 2 | 42 | $4,684 |
See the largest Medicaid services in earlier years
2023
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 139 | $14,174 |
| Short return visit (20+ min) | 271 | $8,136 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 152 | $4,626 |
2022
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 137 | $15,467 |
| Short return visit (20+ min) | 394 | $12,044 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 138 | $4,388 |
2021
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 147 | $17,869 |
| Short return visit (20+ min) | 425 | $16,864 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 167 | $5,250 |
2020
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 243 | $37,078 |
| Short return visit (20+ min) | 468 | $19,973 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 246 | $7,898 |
| New patient visit (30+ min) | 16 | $1,189 |
2019
| Short return visit (20+ min) | 374 | $14,034 |
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 104 | $11,138 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 109 | $2,957 |
2018
| Short return visit (20+ min) | 289 | $3,683 |
| Injection of sclerosant; multiple incompetent veins (other than telangiectasia), same leg | 16 | $1,001 |
Drugs they prescribed that Part D paid
$25,975
Pharmacies billed $25,975 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 23% of their Part D prescriptions (36 of 157) in 2024. Above the middle of the specialty; the typical vascular surgery clinician is at 11%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
135 generic and 22 brand-name prescriptions · $25,975 in drug cost · 14 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 14 | $20,067 | $1,433 |
| Clopidogrel | 49 | $607 | $12 |
| Lidocaine-Prilocaine | 11 | $321 | $29 |
| Hydrocodone-Acetaminophen | 15 | $128 | $9 |
| Tramadol | 13 | $31 | $2 |
Year by year
| 2024 | 157 | 62 | 23% (36) | 14% | $25,975 |
| 2023 | 206 | 59 | 30% (61) | 12% | $17,337 |
| 2022 | 188 | 60 | 26% (49) | None | $10,397 |
| 2021 | 172 | 58 | 29% (49) | 11% | $14,729 |
| 2020 | 131 | 57 | 32% (42) | None | $7,203 |
| 2019 | 91 | 49 | 29% (26) | None | $10,985 |
| 2018 | 135 | 60 | 22% (30) | 11% | $5,865 |
| 2017 | 143 | 69 | 28% (40) | 10% | $8,993 |
| 2016 | 90 | 41 | 13% (12) | 18% | $3,427 |
| 2015 | 206 | 80 | 32% (65) | 13% | $14,464 |
| 2014 | 222 | 93 | 27% (60) | 6% | $6,854 |
| 2013 | 246 | 86 | 27% (67) | 10% | $12,192 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Xarelto | 18 | $13,365 | $742 |
| Clopidogrel | 51 | $614 | $12 |
| Hydrocodone-Acetaminophen | 36 | $296 | $8 |
| Mupirocin | 16 | $248 | $15 |
| Oxycodone-Acetaminophen | 16 | $144 | $9 |
2022: 3 drugs
| Clopidogrel | 53 | $640 | $12 |
| Oxycodone-Acetaminophen | 19 | $201 | $11 |
| Hydrocodone-Acetaminophen | 20 | $169 | $8 |
2021: 4 drugs
| Clopidogrel | 42 | $576 | $14 |
| Oxycodone-Acetaminophen | 20 | $182 | $9 |
| Tramadol | 17 | $80 | $5 |
| Hydrocodone-Acetaminophen | 12 | $78 | $7 |
2020: 3 drugs
| Clopidogrel | 28 | $454 | $16 |
| Oxycodone-Acetaminophen | 18 | $211 | $12 |
| Tramadol | 16 | $46 | $3 |
2019: 2 drugs
| Clopidogrel | 35 | $666 | $19 |
| Hydrocodone-Acetaminophen | 15 | $69 | $5 |
2018: 2 drugs
| Clopidogrel | 51 | $678 | $13 |
| Oxycodone-Acetaminophen | 16 | $163 | $10 |
2017: 4 drugs
| Clopidogrel | 51 | $980 | $19 |
| Lidocaine-Prilocaine | 14 | $296 | $21 |
| Oxycodone-Acetaminophen | 18 | $129 | $7 |
| Tramadol | 11 | $63 | $6 |
2016: 2 drugs
| Clopidogrel | 38 | $996 | $26 |
| Lidocaine-Prilocaine | 24 | $802 | $33 |
2015: 5 drugs
| Xarelto | 11 | $8,914 | $810 |
| Clopidogrel | 68 | $1,084 | $16 |
| Lidocaine-Prilocaine | 21 | $933 | $44 |
| Oxycodone-Acetaminophen | 40 | $573 | $14 |
| Hydrocodone-Acetaminophen | 19 | $203 | $11 |
2014: 4 drugs
| Clopidogrel | 69 | $1,243 | $18 |
| Lidocaine-Prilocaine | 36 | $1,114 | $31 |
| Hydrocodone-Acetaminophen | 24 | $481 | $20 |
| Oxycodone-Acetaminophen | 26 | $306 | $12 |
2013: 5 drugs
| Santyl | 14 | $5,289 | $378 |
| Clopidogrel | 73 | $3,617 | $50 |
| Lidocaine-Prilocaine | 39 | $996 | $26 |
| Hydrocodone-Acetaminophen | 47 | $431 | $9 |
| Oxycodone-Acetaminophen | 15 | $111 | $7 |
Money from drug and device companies
$86 in 2025
| 2025 | 4 | 5 | None | $86 |
| 2024 | 3 | 3 | None | $351 |
| 2023 | 2 | 5 | None | $122 |
| 2022 | 3 | 12 | None | $241 |
| 2021 | 2 | 6 | None | $118 |
| 2020 | 3 | 5 | None | $95 |
| 2019 | 1 | 2 | None | $27 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Viance | $28 | 2 payments
|
| LeMaitre Vascular | Artegraft Vascular Graft | $20 | 1 payment
|
| MIMEDX Group | None | $19 | 1 payment
|
| BSN Medical | Jobst Anti-Em | $18 | 1 payment
|
See all 5 published payments
| BSN Medical | Meals · 2025-11-19 | Jobst Anti-Em | $18 |
| LeMaitre Vascular | Meals · 2025-10-23 | Artegraft Vascular Graft | $20 |
| MIMEDX Group | Meals · 2025-09-12 | None | $19 |
| Medtronic | Meals · 2025-07-23 | Viance | $14 |
| Medtronic | Meals · 2025-03-31 | Fortrex | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $351
| Koya Medical | Dayspring | $307 | 1 payment
|
| Urgo Medical North America | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap | $26 | 1 payment
|
| Medtronic | Hawkone | $18 | 1 payment
|
2023: $122
| Inari Medical | Flowtriever Catheter, S | $73 | 2 payments
|
| Medtronic | Hawkone | $49 | 3 payments
|
2022: $241
| Medtronic | Concertotm | $182 | 9 payments
|
| Tactile Systems Technology | Flexitouch Plus | $35 | 2 payments
|
| Inari Medical | Flowtriever Catheter, S | $24 | 1 payment
|
2021: $118
| Medtronic | Venaseal | $99 | 5 payments
|
| Cook Medical | Zenith | $19 | 1 payment
|
2020: $95
| Maquet Cardiovascular U.S. Sales L.L.C. | Icast | $46 | 2 payments
|
| Tactile Systems Technology | Flexitouch | $29 | 2 payments
|
| Medtronic Vascular | In.Pact Admiral | $21 | 1 payment
|
2019: $27
| Medtronic Vascular | Hawkone | $27 | 2 payments
|
Checkups this office reported
8 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 85.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 0%That's few of the people this applied to. | 577 |
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 284 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 100%That's most of the people this applied to. Worse on this measure. | 76 |
| Medications listed in the chartVisits where the current medication list was documented | 81%That's most of the people this applied to. | 2,273 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 485 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 12% | 2,081 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 75%That's most of the people this applied to. | 184 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 20%That's few of the people this applied to. | 848 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Professional record
- NPI
- 1811936982
- Licence
- CA 20A8760
- Trained
- College of Osteo Med of the Pacific at Pomona, 1994 · 32 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA GR0098310
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X)
- Mailing address
- 2841 N Ventura Rd, Suite 200, Oxnard, CA, 93036
- NPI first listed
- 2006-06-05
- NPI last updated
- 2016-02-10
This is when the NPI record was last certified, not a medical board exam.